References
- Allemani C, Matsuda T, Di Carlo V, et al. Global survey of trends in
cancer survival 2000-14 (CONCORD-3): analysis of individual records
for 37513025 patients diagnosed with one of 18 cancer from 322
population based registrations in 71 countries [J] Lancet, 2018,
391 (10125): 1023-1075. DOI: 10.1016/S0140-6736 (17) 33326-3
- LINDSAY K, SAKET R G. Treatment of Epithelial Ovarian Cancer [J]
BMJ, 2020, 371
- Yang XW, Huang HX, Wang F, Zhou QL, Huang YQ, Qin RZ Elevated plasma
CXCL12/SDF-1 levels are linked with disease severity of post
menopausal osteoporosis Innate Immun 2020; 26:222-30
- Kurnit Katherine C, Fleming Gini F, Lengyel Ernst Updates and New
Options in Advanced Epithelial Ovarian Cancer Treatment [J],
2021137 (1): 108-121
- Wang J, Liu TB, Yu LB, et al. Effect of Aidi injection on SKOV_3
human ovarian cancer cells [J]. Chinese Journal of Modern
Medicine, 2011 (5):582-585.
- Liu Jie, Li Daorui, Chen Hao, et al. Cost-effectiveness analysis of
Aidi injection combined with transcatheter arterial chemoembolization
in the treatment of primary liver cancer [J]. Journal of Clinical
Oncology, 2019, 24 (5):428-433.
- Yang Lingyan, Fan Huizhen. Research progress on the mechanism and
clinical application of matrine and oxymatrine in the treatment of
digestive system tumors [J]. Practical Clinical Medicine, 2016, 17
(5):97-100.
- Yang N, Han F, Cui H, et al. Matrine suppresses promotion and
inducasapoptosis in human cholangiomocarcinoma cells through
suppression of JAK2/STAT3 signaling Pharmacol Rep, 2015,67 (2):
388-393
- Wu J, Hu G, Dong Y, et al. Matrine indices Akt/mTOR signaling
inhibition mediated autophagy and apoptosis in acute myeloid leukeemia
cells J Cell Mol Med, 2017, 21 (6): 1171-1181
- Zhang J, Gao Y, Han H, et al. Matrine suppresses lung metastasis of
human pathocellular cancer by directly targeting matrix
metalloproteinase-9 BiochemBiophys Res Commun, 2019, 515 (1): 57-63
- Zhao XB, Qin Y, Niu YL, et al. Matrine inhibitors
hypoxia/reoxygenation induced apoptosis of cardiovascular
microvascular epithelial cells in rates via the JAK2/STAT3 signaling
pathway Biomed Pharmaceutical, 2018, 106:117-124
- Chen Z, Nishimura N, Okamoto T, et al. Molecular Mechanismof Matrine
from Sophora alopecuroides in the Reversing Effect of Multi Anticancer
Drug Resistance in K562/ADR Cells Biomed Res Int, 2019, 2019:1269532
- Li T, Wong VK, Yi XQ, et al. Matrine induces cell anergy in human
Jurkat T cells through modulation of mitogen activated protein kinases
and nuclear factor of activated T cells signaling with concomitant up
regulation of anergy associated genes expression Biol Pharm Bull,
2010, 33 (1): 40-46
- Monk BJ, et al. ATHENA-MONO (GOG-3020/ENGOT-ov45): A randomized,
double blind, phase 3 trial evaluating rubarian monotherapy versus
placebo as maintenance treatment following response to first line
platinum based chemotherapy in ovarian cancer J Clin Oncol 40, 2022
(supply 17; abstr LBA5500)
- Surgery Improves Retired Ovarian Cancer Surveillance |
Oncology | JAMA | JAMA Network
- Wang BL, Liu Z Q, Zou S Q. Netlike Meta analysis of Chinese herbal
injection combined with chemotherapy in the treatment of ovarian
cancer [J]. Chinese Herbal Medicine and Clinical Pharmacology,
2019, 30 (01):123-130.
- Jing Y J, Yang X J, Hao H X. Matrine inhibits proliferation and
induces apoptosis of human papillary ovarian carcinoma cells via NF-κB
signaling pathway [J]. Chin J Eugenics and Genetics, 2023, 31
(10):2027-2033.
- Zhou J H, Li L P, Wang J J et al. Effect of Aidi injection on serum
CEA, CA153 and HE4 levels in ovarian cancer model rats [J]. Hebei
Medicine, 2019, 41 (10):1490-1493.
- PIGNATA S, S C C, DU BOIS A, et al. Treatment of current ovarian
cancer [J] Ann Oncol, 2017, 28 (suppl_8): viii51 viii6